Cardiogenesis Corporation
Kennesaw
About Cardiogenesis Corporation
Cardiogenesis Corporation designs, develops, and distributes laser-based surgical products and disposable fiber-optic accessories for the treatment of cardiac ischemia associated with advanced cardiovascular disease. The company offers minimally-invasive transmyocardial revascularization fiberoptic delivery, robotic hand piece delivery, and complete console and cardiovascular delivery systems. Additionally, Cardiogenesis provides reimbursement services. Cardiogenesis pioneered the development of Transmyocardial revascularization (TMR) procedures, a method of therapy and treatment for refractive angina that is approved by the American College of Cardiology, American Heart Association, and the Society of Thoracic Surgery. Cardiogenesis was founded in 1989 and is headquartered in Kennesaw, Georgia. As of May 17, 2011, Cardiogenesis Corporation operates as a subsidiary of CryoLife Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Phone: (770)419-3355
Canonical: https://fsome.com/organization/cardiogenesis-corporation-3245876 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.